Studies available for: CMV

See a study that interests you? Contact that study's coordinator for more information on how to participate.


Study Information:
A Randomized, Double-blind, Placebo-controlled, Phase II Study to Assess the Safety and Efficacy of the Cytomegalovirus gB/MF59 Vaccine in Preventing Systemic Cytomegalovirus Infection in Healthy Adolescent Females
Houston, TX
The University of Texas Health Science Center at Houston
Study on a Vaccine to Prevent Cytomegalovirus in Adolescent Girls Underway at UT. The University of Texas Health Science Center at Houston is currently conducting a study about cytomegalovirus (CMV) in adolescent girls. CMV is a common cause of mild upper respiratory illness, sometimes with fever and enlarged lymph nodes, in children of all ages. CMV can be passed from a mother to her unborn infant during pregnancy and cause more serious consequences. We are interested in learning how to prevent this virus in young women. We are recruiting girls 12 to 17 years of age, who: -Have not received a blood or blood product transfusion in 3 months -Have no significant medical illness -Are willing to have blood drawn once (approximately 10cc or 2 teaspoons), -Can come to the University of Texas Clinical Research Unit. The visit will be approximately 1 hour long and your parking will be reimbursed. Volunteers will receive $40 for their time and will receive a certificate acknowledgi
HSC-SPH-08-0542
NIH
Subject Information:
12 to 17
Inclusion Criteria 1. Subject is willing and able to provide written informed assent and provides assent prior to study enrollment; parent(s) or legal guardian provides written informed consent prior to study enrollment. 2. Female and 12 to 17 years of age (at time of screening). 3. Subject is willing to consider participation in the experimental CMV vaccine portion of the study which is 31-months in duration and must not be planning to relocate from the study area. 4. Subject is using or willing to consider using effective methods of birth control. This includes abstinence or if sexually active using an effective method of birth control (eg, oral contraceptives; diaphragm or condom in combination with contraceptive jelly
Study Coordinator(s) Information:
Monika Ruscheinsky
monika.ruscheinsky@uth.tmc.edu
713-704-0825
Principal Investigator Information:
Herbert Dupont